Edition:
United States

Aceto Corp (ACET.OQ)

ACET.OQ on NASDAQ Stock Exchange Global Select Market

2.93USD
1:03pm EDT
Change (% chg)

$-0.05 (-1.68%)
Prev Close
$2.98
Open
$2.97
Day's High
$3.08
Day's Low
$2.91
Volume
38,079
Avg. Vol
175,133
52-wk High
$17.10
52-wk Low
$2.22

Chart for

About

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $91.75
Shares Outstanding(Mil.): 30.79
Dividend: 0.01
Yield (%): 1.34

Financials

  ACET.OQ Industry Sector
P/E (TTM): -- 28.26 32.60
EPS (TTM): -5.53 -- --
ROI: -31.96 13.20 12.74
ROE: -64.52 14.98 14.66

BRIEF-Aceto To Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts

* ACETO TO APPEAL U.S. GOVERNMENT RULING REGARDING CERTAIN LUCID PHARMA CONTRACTS

Feb 27 2018

BRIEF-Aceto Appoints Edward Borkowski Chief Financial Officer

* ACETO CORP - APPOINTS EDWARD BORKOWSKI AS CFO EFFECTIVE FEB 21, 2018 Source text for Eikon: Further company coverage:

Feb 16 2018

BRIEF-Aceto Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25Mg, 50Mg And 100Mg

* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES ATENOLOL TABLETS, 25MG, 50MG AND 100MG

Feb 07 2018

BRIEF-Aceto Q2 Loss Per Share $0.39

* IN QUARTER, NET LOSS INCLUDES $13.9 MILLION OF ADDITIONAL INCOME TAX EXPENSE ASSOCIATED WITH TAX CUTS AND JOBS ACT

Feb 01 2018

BRIEF-Aceto's Unit Launches Efavirenz Capsules, 50Mg, 200Mg

* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES EFAVIRENZ CAPSULES, 50MG AND 200MG

Jan 02 2018

Earnings vs. Estimates